MDXG
MiMedx Group Inc
4.70$
-1.3%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 18.1% | 15.9% | 15.6% | 17.3% | 18.2% | 18.2% | 18.8% | 18.9% | 16.5% | 16.1% | 29.4% | 31.0% | 21.2% | |
| 81.9% | 84.1% | 84.4% | 82.7% | 81.8% | 81.8% | 81.2% | 81.1% | 83.5% | 83.9% | 70.6% | 69.0% | 78.8% | |
| 3.8% | 2.8% | 3.4% | 3.5% | 3.5% | 3.8% | 3.8% | 3.3% | 3.3% | 4.0% | 7.0% | 4.3% | 4.3% | |
| 64.3% | 62.6% | 65.1% | 63.5% | 63.7% | 65.7% | 68.0% | 16.5% | 13.4% | 61.9% | 15.8% | 20.8% | 31.3% | |
| 68.3% | 66.2% | 69.1% | 56.1% | 68.5% | 69.9% | 71.9% | 68.5% | 64.0% | 65.9% | 97.8% | 97.6% | 76.3% | |
| 13.6% | 17.8% | 15.6% | 26.9% | 13.3% | 11.9% | 9.4% | 12.5% | 19.5% | 17.8% | -27.2% | -28.7% | 2.5% | |
| 2.1% | 1.8% | 2.0% | 0.0% | 0.3% | 2.7% | 0.5% | 0.5% | 0.7% | 0.3% | 0.7% | – | – | |
| 11.5% | 16.0% | 13.5% | 26.6% | 13.6% | 12.1% | 9.8% | 13.2% | 20.1% | 18.5% | -26.0% | -27.6% | 3.2% | |
| 0.7% | -43.0% | 2.8% | 6.4% | 4.2% | 4.1% | 1.8% | 3.4% | 5.4% | 5.6% | -7.6% | -4.6% | 1.5% | |
| 10.4% | 61.6% | 10.9% | 20.2% | 9.6% | 8.0% | 8.0% | 9.8% | 14.7% | 12.9% | -18.4% | -23.1% | 1.8% | |
| 14.6% | 18.8% | 16.6% | 27.9% | 15.0% | 15.2% | 14.0% | 16.9% | 25.4% | 21.5% | -23.2% | -26.3% | 6.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.